¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Familial primary pulmonary hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • orthostatic hypertension
    ±â¸³°íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð, ½ÅÀ强°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • extralobar pulmonary sequestration
    ¿±¿ÜÇãÆÄºÐ¸®Áõ, ¿±¿ÜÆóºÐ¸®Áõ
  • hypertrophic pulmonary osteoarthropathy
    ºñ´ë¼ºÆó»À°üÀýº´(Áõ)
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
  • hantavirus pulmonary syndrome
    ÇÑŸ¹ÙÀÌ·¯½ºÆóÁõÈıº
  • idiopathic pulmonary fibrosis
    Ư¹ßÆó¼¶À¯Áõ
  • intralobar pulmonary sequestration
    ¿±³»ÇãÆÄºÐ¸®Áõ, ¿±³»ÆóºÐ¸®Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulmonary insufficiency
    Æó±â´ÉºÎÁ·, ÇãÆÄ±â´ÉºÎÁ·
  • pulmonary
    Æó-, ÇãÆÄ-
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð, ÇãÆÄµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð, ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð
  • total pulmonary resistance
    ÆóÇ÷°üÀúÇ×, ÇãÆÄÇ÷°üÀúÇ×
  • pulmonary sequestration
    ÆóºÐ¸®Áõ, ÇãÆÄºÐ¸®Áõ
  • pulmonary surfactant
    ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄ°è¸éȰ¼ºÃ¼
  • pulmonary perfusion scan
    Æó°ü·ù½ºÄµ, ÇãÆÄ°ü·ù½ºÄµ
  • pulmonary trunk
    Æóµ¿¸Æ, ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary thromboembolism
    ÆóÇ÷Àü»öÀüÁõ, ÇãÆÄÇ÷Àü»öÀüÁõ
  • pulmonary function test
    Æó±â´É°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ocular hypertension
    °í¾È¾ÐÁõ
  • orthostatic hypertension
    ±â¸³°íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • rebound hypertension
    ¹Ýµ¿°íÇ÷¾Ð
  • red hypertension
    È«Á¶°íÇ÷¾Ð, ºÓÀº°íÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸°íÇ÷¾ÐÁöÇ¥
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´Áõ
  • pulmonary actinomycosis
    ÇãÆÄ¹ÙÄû»ì±ÕÁõ, Æó¹æ¼±±ÕÁõ
  • pulmonary alveolus
    ÇãÆÄ²Ê¸®, ÆóÆ÷
  • pulmonary arch
    ÇãÆÄµ¿¸ÆÈ°
  • pulmonary arteriosclerosis
    Æóµ¿¸Æ°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • hypertension,portal
    ¹®¸Æ¼º(Ú¦Øæàõ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(Ú¦ØæÍÔúìäâ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø).
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø)
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð(ãìàõÍÔúìäâ).
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð(¡­ÍÔúìäâ)
  • primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, primary
    ÀÏÂ÷°¨¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intracranial hypertension
    µÎ°³³»°íÇ÷¾Ð (¡­ÍÔúìäâ).
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾Ð(Áõ).
  • kallikrein-kinin,renal hypertension
    ½Å¼º°íÇ÷¾Ð(½Å¼º ÍÔúìäâ)
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð (¡­ÍÔúìäâ).
  • low renin essential hypertension
    Àú·¹´Ñ¼º º»Å¼º °íÇ÷¾Ð(­àõÜâ÷¾àõÍÔúì äâ).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(ÊÙË­Ì´ËâÌ¡).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • nephrogenous hypertension
    ½Å¼º°íÇ÷¾Ð (~ÍÔúìäâ).
  • ocular hypertension
    °í¾È¾ÐÁõ
  • ocular hypertension indicator =OHI
    ¾È±¸°íÇ÷¾ÐÁöÇ¥(äÑϹÍÔúìäâò¦øö).
  • orthostatic hypertension
    ±â¸³¼º °íÇ÷¾Ð.
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(Ú¦ØæÍÔúìäâ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ
  • rebound hypertension
    ¹Ýµ¿¼º °íÇ÷¾Ð.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Pulmonary bud
    ÇãÆÄ½Ï
    [¿¾ ¿ë¾î] Æó·Ú
  • Pulmonary ligament
    ÇãÆÄÀδë
    [¿¾ ¿ë¾î] Æó°£¸·
  • Pulmonary vein
    ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÆóÁ¤¸Æ
  • Orifices of pulmonary veins
    ÇãÆÄÁ¤¸Æ±¸¸Û
    [¿¾ ¿ë¾î] ÆóÁ¤¸Æ±¸
  • Visceral [pulmonary] pleura
    ÇãÆÄÂʰ¡½¿¸·
    [¿¾ ¿ë¾î] ÆóÈ丷
  • Diploid primary gametocyte
    µÎ¹è¼öüÀÏÂ÷»ý½Ä¼¼Æ÷
    [¿¾ ¿ë¾î] ¹è¼öüÁ¦ÀÏ»ý½Ä¼¼Æ÷
  • Reticulofibrous membranous bone [Primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À [ÀÏÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÏÂ÷¸·¼º°ñ
  • Premaxilla (Primary palate)
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ¾ÇÀü±¸°³
  • Premaxilla [Primary palate]
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] Àü»ó¾Ç°ñ
  • Primary vitelline sac
    ¿ø½Ã³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ¿ø½Ã³­È²³¶
  • Primary amnion
    ¿ø½Ã¾ç¸·
    [¿¾ ¿ë¾î] ¿ø½Ã¾ç¸·
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£[ÀÏÂ÷»À¼ÓÁú°ø°£]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • Primary bronchus
    ÀÏÂ÷±â°üÁö
    [¿¾ ¿ë¾î] ¿ø½Ã±â°üÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary protein derivative
    ÀÏÂ÷ ´Ü¹éÁúÀ¯µµÃ¼
  • primary response
    ÀÏÂ÷ ´ëÀÀ(ìéó­Óßëë)
  • primary solvent
    ÀÏÂ÷ ¿ë¸Å(ìéó­éÁØÚ)
  • primary standard
    ÀÏÂ÷ Ç¥ÁØ(ìéó­øöñÞ)
  • primary stimulus
    ÀÏÂ÷ ÀÚ±Ø(ìéó­í©Ð½)
  • primary structure
    ÀÏÂ÷±¸Á¶(ìéó­Ï°ðã)
  • primary tissue culture
    ÀÏÂ÷ Á¶Á÷¹è¾ç(ìéó­ðÚòÄÛÆå×)
  • primary transcript
    ÀÏÂ÷ Àü»çü(ìéó­ï®ÞÐô÷)
  • primary tumor
    ¿ø¹ß¼º Á¾¾ç(ê«Û¡àõðþåË)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulmonary angiography
    ÆóÇ÷°üÁ¶¿µ(¼ú)
  • pulmonary artery
    Æóµ¿¸Æ
  • pulmonary aspergillosis
    Æó¾Æ½ºÆä¸£±æ·ç½ºÁõ
  • pulmonary atelectasis
    ¹«±âÆó
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â(Áõ)
  • pulmonary capillary
    Æó¸ð¼¼°ü
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulmonary circulation
    Æó¼øÈ¯
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • pulmonary congestion
    Æó¿ïÇ÷
  • pulmonary edema
    ÆóºÎÁ¾
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ
  • pulmonary emphysema
    Æó±âÁ¾
  • pulmonary eosinophilia
    ÆóÈ£»ê±¸Áõ°¡Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
PCP parachlorophenate; patient care plan; pentachlorophenol; 1-(1-phenylcyclohexyl)piperidine; periphera...
FHH Familial Hypocalciuric Hypercalcemia
  = Familial Benign Hypercalcemia
FAD familial Alzheimer dementia; familial autonomic dysfunction; fetal activity-acceleration determinati...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAH pulmonary artery hypertension
PHS pulmonary hypertension syndrome
BFNC Benign Familial Neonatal Convulsions
FAD Familial Alzheimer's disease
FALS Familial ALS
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • familial hypophosphatemic rickets

    familial leiomyomatosis cutis et uteri (°¡Á·¼º ÇǺΠÀڱà ±ÙÁ¾Áõ

  • familial Mediterranean fever
    °¡Á·¼º ÁöÁßÇØ ¿­
  • familial neutropenia
    °¡Á·¼º È£Áß±¸ °¨¼ÒÁõ
  • familial polyposis
    °¡Á·¼º Æú¸³Áõ
  • familial progressive sensorineural hearing loss
    °¡Á·¼º ÁøÇ༺ °¨°¢ ½Å°æ¼º ³­Ã»
  • familial teleangiectasis
    °¡Á·¼º ¸»ÃÊÇ÷°ü È®Àå, °¡Á·¼º ¸»ÃÊÇ÷°ü È®ÀåÁõ
  • fatal familial insomnia
    Ä¡¸íÀû °¡Á·¼º ºÒ¸éÁõ
    ºÒ¸éÁõ°ú ÀÚÀ²½Å°æ Àå¾Ö°¡ ÁÖ Áõ»óÀÌ°í ¸ðµç ȯÀÚ¿¡¼­ PrP À¯ÀüÀÚÀÇ º¯À̸¦ È®ÀÎÇÒ ¼ö ÀÖ´Ù. ÇüÅÂÇÐÀû ¼Ò°ßÀº º¸Åë ½Ã»ó¿¡¼­¸¸ °üÂûµÇ´Âµ¥ ½Å°æ ¼¼Æ÷ÀÇ ¼Ò½Ç°ú ´õºÒ¾î ±³¼¼Æ÷°¡ Áõ½ÄÇϰí ÇØ¸é»ó º¯È­¸¦ º¸ÀδÙ.
  • absent pulmonary valve syndrome
    Æó µ¿¸Æ ÆÇ °á¿© ÁõÈıº
    ´Üµ¶À¸·Î ÀϾ´Â °æ¿ì´Â ±ØÈ÷ µå¹°¸ç, ½É½Ç Áß°Ý °á¼Õ, ¿ì½Ç ´©µÎºÎ ÇùÂø¿¡ ÇÕº´ÇÏ´Â °æ¿ì°¡ ºñ±³Àû ¸¹´Ù. Áï Fallot 4ÁõÈÄÀÇ ÇÕº´ ±âÇüÀ¸·Î ³ªÅ¸³­´Ù. ÀÌ °æ¿ì ÁÂ¿ì Æóµ¿¸ÆÀÇ È®´ë, ¥±À½ Æóµ¿¸Æ ¼ººÐÀÇ ¿ÏÀü ¼Ò½Ç, ÇÇÄ¡°¡ ³·Àº È®Àå±â ÀâÀ½À» ³ªÅ¸³½´Ù. À̰ÍÀ» µ¿¹ÝÇÑ Fallot 4ÁõÈÄ´Â À¯¾Æ±â¿¡ ¿ïÇ÷¼º ½ÉºÎÀüÀ» ÀÏÀ¸Å°±â ½±´Ù.
  • eosinophilic pulmonary syndrome
    È£»ê¼º Æó ÁõÈıº
    ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÆóÆ÷ ¼¼Ã´À̳ª »ý°Ë»ó È£»ê±¸°¡ Æó Á¶Á÷ÀÇ ¸»Ãʺο¡ Ä§ÂøµÈ ¼Ò°ßÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ» ÀǹÌÇÑ´Ù. Ç÷¾× È£»ê±¸ Áõ°¡°¡ ´ëºÎºÐ °üÂûµÈ´Ù. ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÁÖ·Î ¿©ÀÚ¿¡ ³ªÅ¸³ª¸ç, ¹ß¿­, ¹ßÇÑ, üÁß °¨¼Ò, È£Èí °ï¶õÀÌ Æ¯Â¡ÀÌ´Ù. Ä¡·á´Â °æ±¸
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº Æó °ñ°üÀýº´Áõ
  • left inferior pulmonary vein
    ¾Æ·¡ ¿Þ ÇãÆÄ Á¤¸Æ
  • main pulmonary artery
    ÁÖ Æó µ¿¸Æ
  • mediastino pulmonary
    Á¾°Ý Æó
  • mild pulmonary valve stenosis
    °æµµÀÇ Æó µ¿¸ÆÆÇ ÇùÂøÁõ
  • multiple pulmonary emboli
    ´Ù¹ß¼º Æó »öÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
ocular hypertension A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
(12 Dec 1998)
essential hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
labile hypertension Frequently changing levels of elevated blood pressure.
(05 Mar 2000)
benign familial chorea A rare, nonprogressive movement disorder characterised by chorea and athetosis appearing in early childhood, most commonly manifested as gait ataxia and upper limb coordination. Intellect is unaffected. Probably autosomal-dominance inheritance with incomplete penetrance.
(05 Mar 2000)
benign familial chronic pemphigus Recurrent eruption of vesicles and bullae that become scaling and crusted lesions with vesicular borders, predominantly of the neck, groin, and axillary regions; autosomal dominant inheritance, presenting in late adolescence or early adult life.
Synonym: Hailey-Hailey disease.
(05 Mar 2000)
benign familial icterus Mild jaundice due to increased amounts of unconjugated bilirubin in the plasma without evidence of liver damage, biliary obstruction, or haemolysis; thought to be due to an inborn error of metabolism in which the excretion of bilirubin by the liver is defective, ascribed to decreased conjugation of bilirubin as a glucuronide or impaired uptake of hepatic bilirubin.
Synonym: benign familial icterus, constitutional hepatic dysfunction, Gilbert's disease, Gilbert's syndrome, Hebra's disease.
(05 Mar 2000)
cancer, breast, familial A number of factors have been identified that increase the risk of breast cancer. One of the strongest of these risk factors is the history of breast cancer in a relative. About 15-20% of women with breast cancer have such a family history of the disease, clearly reflecting the participation of inherited (genetic) components in the development of some breast cancers. Dominant breast cancer suceptibility genes, including BRCA1 and BRCA2, appear responsible for about 5% of all breast cancer.
(12 Dec 1998)
paralysis, familial periodic An autosomal dominant trait marked by recurring attacks of rapidly progressive flaccid paralysis. There are three types: I, associated with a fall in serum potassium levels (hypokalaemic periodic paralysis); II, associated with a rise therein (hyperkalaemic periodic paralysis, called also adynamia episodica hereditaria); and III, with normal levels (normokalaemic periodic paralysis).
(12 Dec 1998)
pemphigus, benign familial Rare hereditary disease characterised by recurrent eruptions of vesicles and bullae mainly on the neck, axillae, and groin. It exhibits autosomal dominant inheritance and is unrelated to pemphigus vulgaris though it closely resembles that disease.
(12 Dec 1998)
chronic familial icterus <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane.
This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged.
Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal.
(27 Sep 1997)
chronic familial jaundice <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane.
This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged.
Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal.
(27 Sep 1997)
chronic familial polyneuritis Inflammation of nerves related to infiltration by amyloid.
(05 Mar 2000)
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
hypercholesterolaemia, familial A familial disorder characterised by increased plasma concentration of cholesterol carried in low density lipoproteins (ldl) and by a deficiency in a cell surface receptor which regulates ldl degradation and cholesterol synthesis. It is frequently associated with arcus senilis and premature atherosclerosis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary meeting
    ¿¹¼± ´ëȸ;»çÀü ÇùÀÇȸ
  • primary planet
    Ç༺
  • primary producer
    Á¦1Â÷ »ý»êÀÚ(±¤ÇÕ¼º¿¡ ÀÇÇØ ¹«±â¹°¿¡¼­ À¯±â¹°À» »ý»êÇÏ´Â ½Ä¹°)
  • primary production
    1Â÷ »ý»ê(±¤ÇÕ¼º »ý¹°¿¡ ÀÇÇÑ À¯±â¹°ÀÇ »ý»ê)
  • primary products
    ³ó»ê¹°
  • primary root
    ÁÖ±Ù
  • primary school
    ±¹¹ÎÇб³;»ïÇгâ±ÞÀÇ ±¹¹Î Çб³
  • primary stress
    =PRIMARY ACCENT
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • primary tenses
    (¶óƾ,±×¸®½º¾îÀÇ) Á¦ 1½ÃÁ¦(ÇöÀç,¹Ì·¡,°ú°Å ¶Ç´Â ¿Ï·áÀÇ ÃÑĪ)
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á